Operating Lease, Right-of-Use Asset of Cartesian Therapeutics, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cartesian Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Cartesian Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,972,000, a 63% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Cartesian Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,972,000 -$8,551,000 -63% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $5,164,000 -$8,688,000 -63% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $5,351,000 -$4,205,000 -44% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $5,535,000 -$4,533,000 -45% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $13,523,000 +$3,184,000 +31% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $13,852,000 +$3,077,000 +29% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $9,556,000 -$1,645,000 -15% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $10,068,000 -$1,549,000 -13% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 $10,339,000 -$1,717,000 -14% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $10,775,000 +$1,537,000 +17% 30 Jun 2023 10-Q 17 Aug 2023 2023 Q2
Q1 2023 $11,201,000 +$1,665,000 +17% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $11,617,000 +$1,788,000 +18% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 $12,056,000 +$1,939,000 +19% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $9,238,000 -$1,161,000 -11% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $9,536,000 -$1,140,000 -11% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $9,829,000 -$1,119,000 -10% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $10,117,000 -$1,099,000 -9.8% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $10,399,000 -$1,075,000 -9.4% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $10,676,000 -$1,171,000 -9.9% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $10,948,000 +$10,647,000 +3537% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 $11,216,000 +$10,622,000 +1788% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $11,474,000 +$10,596,000 +1207% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $11,847,000 +$10,692,000 +926% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $301,000 31 Dec 2019 10-K 12 Mar 2021 2020 FY
Q3 2019 $594,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $878,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $1,155,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.